Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FHOD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | TSC22D4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BCKDK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RP11-211G3.2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | COQ10A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NCKAP5L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TEX35 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MT1H | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |